FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
FcepsilonRI, The high affinity receptor for IgE plays a critical role in triggering the allergic reactions. It is responsible for inducing mast cell degranulation and deliberation of allergy mediators when it is aggregated by allergen and IgE complexes. FcepsilonRI on the mast cells consists of three subunits; alpha chain directly binds IgE, beta chain and dimmer of gamma chains together mediate intracellular signaling. Cross-linking of IgE-bound FcepsilonRI on the surface of mast cells and basophils by the multivalent antigen induces release of chemical mediators. The present in vitro study was designed to investigate the effect of synthetic FcepsilonRI-alpha siRNA on the antigen-induced activation of MC/9 cells. MC/9 cells which are murine mast cells were transfected by FcepsilonRI-alpha siRNA and negative control siRNA. After 6 h, anti-DNP (Dinitrophenyl) IgE was used for the cells sensitization. Then the cells were challenged with Dinitrophenyl-Human Serum Albumin (DNP-HSA) for mast cell degranulation induction before collection of supernatants. The amount of mRNA and protein expression was measured by Real Time PCR and western blot analysis, respectively. Determination of the expression rate of FcepsilonRI-alpha on cell surface was achieved by flow cytometry. ELISA and spectrophotometry methods were used subsequently for measuring the effects of FcepsilonRI-alpha siRNA on antigen-induced histamine and beta-hexosaminidase release. FcepsilonRI-alpha siRNA treated cells showed significant decrease in FcepsilonRI-alpha mRNA and protein expression in comparison to control cells. FcepsilonRI-mediated mast cell release of beta-hexosaminidase and histamine were also inhibited. In this study it was shown that FcepsilonRI-alpha siRNA could suppress FcepsilonRI-alpha expression and inhibited degranulation and histamine release in antigen-stimulated MC/9 cells. In conclusion, knock-down of FcepsilonRI-alpha by siRNA could be a promising method for inhibition of the mast cell-mediated allergic reactions.
Safaralizadeh
Reza
R
Department of Biochemistry, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Soheili
Zahra-Soheila
ZS
Deezagi
Abdolkhaleg
A
Pourpak
Zahra
Z
Samiei
Shahram
S
Moin
Mostafa
M
D000485:Allergens / Q000276:immunology / Q000378:metabolism; D000818:Animals; D000941:Antigens / Q000276:immunology* / Q000378:metabolism / Q000494:pharmacology; D001249:Asthma / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D001491:Basophils / Q000276:immunology / Q000378:metabolism; D015550:Cell Degranulation / Q000187:drug effects / Q000235:genetics / Q000276:immunology*; D002460:Cell Line; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D006632:Histamine / Q000276:immunology / Q000378:metabolism; D006636:Histamine Release / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology* / Q000378:metabolism / Q000494:pharmacology; D007152:Immunologic Capping; D008407:Mast Cells / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D034741:RNA, Small Interfering / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D017455:Receptors, IgE / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology*
D000485:Allergens; D000941:Antigens; D034741:RNA, Small Interfering; D017455:Receptors, IgE; D007073:Immunoglobulin E; D006632:Histamine